Expertise in
1
conditions

Bas H. Kietselaer

Heerlen, LI, NL 
Expertise in
1
conditions
Heerlen, LI, NL 

Overview

Bas Kietselaer practices practicing medicine in Heerlen, Netherlands.

Ms. Kietselaer is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Acute Coronary Syndrome, Coronary Heart Disease, Calcinosis, and Heart Attack.

She is actively involved in clinical research, co-authoring 72 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Heerlen, LI, Netherlands
Other Locations
Maastricht, LI, Netherlands
Sittard, LI, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination With Filgrastim in Early Recovery Post-Myocardial Infarction
Enrollment Status: Completed
Publish Date: May 27, 2021
Intervention Type: Drug
Study Phase: Phase 2
The Value of Echocardiography for Prediction of Radiation-induced Lung Injury in Non-small Cell Lung Cancer Patients Treated With Chemoradiation: an Onco-cardiac Prospective Cohort Study.
The Value of Echocardiography for Prediction of Radiation-induced Lung Injury in Non-small Cell Lung Cancer Patients Treated With Chemoradiation: an Onco-cardiac Prospective Cohort Study.
Enrollment Status: Terminated
Publish Date: December 04, 2019
View 1 Less Clinical Trial

72 Total Publications

Routine cerebral embolic protection during TAVR: A meta-analysis and trial sequential evidence from 11,000 randomized patients.
Routine cerebral embolic protection during TAVR: A meta-analysis and trial sequential evidence from 11,000 randomized patients.
Journal: Journal of cardiology
Published: February 26, 2026

Frequently Asked Questions about Bas H. Kietselaer

Is Bas H. Kietselaer a top-rated expert for Acute Coronary Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Bas H. Kietselaer is classified as an Advanced expert for Acute Coronary Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Bas H. Kietselaer participate in research or clinical trials?

Yes. Bas H. Kietselaer has published 72 articles and abstracts on conditions like Acute Coronary Syndrome. You can view a list of Bas H. Kietselaer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Kietselaer's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile